A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples